Key result
Habitual coffee consumption is linked to ~21% lower copeptin levels in ADPKD.
Why the study?
The relationships between coffee consumption, serum copeptin, and cardiac parameters in patients with autosomal dominant polycystic kidney disease (ADPKD) remain unclear.
Does habitual coffee consumption improve serum copeptin concentrations and echocardiographic parameters of diastolic function in patients with ADPKD?
Cross-Sectional (n=73)
Does habitual coffee consumption improve serum copeptin concentrations and echocardiographic parameters of diastolic function in patients with ADPKD?
Habitual coffee consumption in ADPKD patients is associated with improved echocardiographic markers of diastolic myocardial relaxation and potentially lower serum copeptin levels.
Answers are grounded in this paper and cite their sources.
Should not yet change coffee recommendations in ADPKD; leaves open vasopressin and diastolic effects for prospective trials.
Background/Objectives: Coffee consumption has been suggested to influence arginine vasopressin-related pathways and cardiovascular function. However, its relationships with serum copeptin and cardiac parameters in patients with autosomal dominant polycystic kidney disease (ADPKD) remain unclear. This study aimed to investigate the association between habitual coffee consumption and serum copeptin concentrations and selected echocardiographic parameters in patients with ADPKD. Methods: In this cross-sectional study, 73 patients with ADPKD were classified as coffee consumers (n = 35) or non-consumers (n = 38). Serum copeptin measurements were available for 62 patients. Coffee consumption was assessed using a standardized questionnaire and expressed as grams of dry coffee per month. Multivariable models were used to assess associations with log-transformed copeptin, mitral annular e′ velocity, and E/e′ ratio. Results: Serum copeptin levels were lower among coffee consumers than non-consumers (median, 263.51 vs. 332.77 ng/L; p = 0.013). After adjustment, coffee consumption was associated with lower log-transformed copeptin levels (B = −0.263; p = 0.047), although this association was not statistically significant when using heteroskedasticity-consistent (HC3) robust standard errors (p = 0.074). Coffee consumers had higher mitral annular e′ velocity (8.61 vs. 5.86 cm/s; p < 0.001), which remained significant after adjustment (B = 2.531; p < 0.001), and a lower E/e′ ratio (B = −4.548; p = 0.007). Conclusions: In this ADPKD cohort, coffee consumption was associated with lower serum copeptin levels, higher mitral annular e′ velocity, and lower E/e′ ratio. These findings raise the hypothesis that habitual coffee consumption may be associated with vasopressin–copeptin system activity and diastolic myocardial relaxation in patients with ADPKD. However, the copeptin association was not robust to HC3 analysis, and the echocardiographic findings should be considered exploratory.
No takes yet. Share an insight, caveat, or question.
Esen et al. (2026) conducted a cross-sectional in autosomal dominant polycystic kidney disease (ADPKD) (n=73). Coffee consumption vs. Non-consumers was evaluated on Serum copeptin levels (B = -0.263, p=0.047). Habitual coffee consumption in patients with ADPKD was associated with lower serum copeptin levels (median 263.51 vs 332.77 ng/L; p=0.013) and higher mitral annular e' velocity (p<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: